0001213900-26-050133.txt : 20260430 0001213900-26-050133.hdr.sgml : 20260430 20260430153810 ACCESSION NUMBER: 0001213900-26-050133 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260128 FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Graff Jeremy R. CENTRAL INDEX KEY: 0001975028 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41160 FILM NUMBER: 26924354 MAIL ADDRESS: STREET 1: C/O IN8BIO, INC. STREET 2: 350 5TH AVENUE, SUITE 5330 CITY: NEW YORK STATE: NY ZIP: 10118 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Allarity Therapeutics, Inc. CENTRAL INDEX KEY: 0001860657 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 BUSINESS PHONE: 401-426-4664 MAIL ADDRESS: STREET 1: 24 SCHOOL ST., 2ND FLOOR CITY: BOSTON STATE: MA ZIP: 02108 4/A 1 ownership.xml OWNERSHIP DOCUMENT X0609 4/A 2026-01-28 2026-01-16 0 0001860657 Allarity Therapeutics, Inc. ALLR 0001975028 Graff Jeremy R. false C/O ALLARITY THERAPEUTICS, INC. 123 E TARPON AVE TARPON SPRINGS FL 34689 0 1 0 0 See Remarks 0 Common Stock 2026-01-28 4 A 0 133333 0 A 381644 D The restricted stock units, or RSUs, granted on January 28, 2026 pursuant to Allarity Therapeutics, Inc's Amended and Restated 2021 Equity Incentive Plan, will vest in equal one-third installments on the first, second, and third anniversary of the grant, subject to the Reporting Person's continued relationship with the Issuer through each such date. President and Chief Development Officer /s/ Jeremy R. Graff 2026-04-30